Tigress Financial Maintains Buy on Dolby Laboratories, Lowers Price Target to $112
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $116 to $112.
Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $116 to $112.